ePatientFinder to connect patients to trials, providers with Rep Network partnership
ePatientFinder has signed a two-year agreement with Rep Network through which it will expand clinical trial access across the United States.
Archives for April 23, 2017
DSM Sinochem to up capacity at Delft antibiotic intermediates plant
DSM Sinochem (DSP) has announced its intention to increase antibiotic production capacity at its facility in Delft, the Netherlands.
IriSys clinical trial material manufacturing contract upped to $6m
IriSys LLC has been awarded an increase to its five-year prime vendor contract – an agreement now worth up to $6m.
Medidata adding eConsent via Mytrus acquisition
Medidata is set to acquire Mytrus, Incorporated – adding eConsent and remote monitoring solutions for a "modern trial experience."
WHO pressures Big Pharma to donate more drugs for tropical diseases
The World Health Organisation (WHO) has urged pharma companies to help combat neglected tropical diseases (NTDs) via increased drug donations.
US FDA issues Sun with Form 483 after Dadra plant inspection
The US FDA has handed Sun Pharmaceutical Industries Ltd a Form 483 detailing critical observations made during an inspection of its Dadra, India facility.
Certara launches CDISC PK solution
Certara has launched a new solution for preparing, analyzing, and submitting pharmacokinetic (PK) data in Clinical Data Interchange Standards Consortium (CDISC) format.
Samsung Bioepis to take on J&J with FDA approved Remicade biosimilar
Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.